Johnson & Johnson deserves more credit for another healthy quarter and strong guidance
The new year has been tough on pharmaceutical stocks, including JNJ. But it should not be read as an indictment
Read MoreThe new year has been tough on pharmaceutical stocks, including JNJ. But it should not be read as an indictment
Read MoreBig day of earnings for Club holdings as the Dow, S&P 500 and Nasdaq look to open lower after back-to-back
Read MoreThese are the stocks posting the biggest moves in early trading. Source link
Read MoreHere are the most important news items that investors need to start their trading day. Source link
Read MoreThe corporate earnings season ramps up this week, as investors look for more clarity on how companies are weathering persistent
Read MoreThese are the key economic reports and earnings results to watch. Source link
Read MoreHere are the biggest calls on Wall Street on Source link
Read MoreThe Club is growing increasingly worried about some richly valued companies in our portfolio. These six stocks look better positioned.
Read MoreIf you're reading this, you've made it through the worst year for stocks since 2008. Source link
Read More